ALT - SEC Form 4 insider transactions

SEC Form 4 filed by Director Lawver Teri L

SEC Form 4 filed by Director Sohn Catherine A.

SEC Form 4 filed by Director Jorkasky Diane

SEC Form 4 filed by Director Schafer Klaus

SEC Form 4 filed by Director Pisano Wayne

SEC Form 4 filed by Director Hodges Philip

SEC Form 4 filed by Director Gill John

SEC Form 4 filed by Director Sayare Mitchel

SEC Form 4 filed by Gill John

SEC Form 4 filed by Weaver Gregory L

SEC Form 4 filed by Durso Jerome Benedict

SEC Form 4 filed by Chief Scientific Officer Roberts M Scot

SEC Form 4 filed by Chief Financial Officer Weaver Gregory L

Chief Scientific Officer Roberts M Scot converted options into 17,050 shares, covered exercise/tax liability with 5,188 shares and was granted 5,567 shares, increasing direct ownership by 18% to 112,824 units (SEC Form 4)

Director Garg Vipin K converted options into 26,775 shares, covered exercise/tax liability with 11,632 shares and was granted 6,926 shares, increasing direct ownership by 5% to 424,519 units (SEC Form 4)

Chief Business Officer Jordt Raymond M was granted 4,571 shares, increasing direct ownership by 7% to 70,107 units (SEC Form 4)

Chief Business Officer Jordt Raymond M converted options into 15,850 shares and covered exercise/tax liability with 4,229 shares, increasing direct ownership by 22% to 65,536 units (SEC Form 4)

Director Garg Vipin K converted options into 41,200 shares and covered exercise/tax liability with 17,898 shares, increasing direct ownership by 6% to 402,450 units (SEC Form 4)

Chief Scientific Officer Roberts M Scot converted options into 15,850 shares and covered exercise/tax liability with 4,748 shares, increasing direct ownership by 13% to 95,395 units (SEC Form 4)

Chief Business Officer Jordt Raymond M converted options into 14,600 shares and covered exercise/tax liability with 3,855 shares, increasing direct ownership by 25% to 53,915 units (SEC Form 4)

Director Garg Vipin K converted options into 42,050 shares and covered exercise/tax liability with 17,984 shares, increasing direct ownership by 7% to 379,148 units (SEC Form 4)

Chief Scientific Officer Roberts M Scot converted options into 14,600 shares and covered exercise/tax liability with 4,373 shares, increasing direct ownership by 14% to 84,293 units (SEC Form 4)

Chief Business Officer Jordt Raymond M converted options into 9,375 shares and covered exercise/tax liability with 2,475 shares, increasing direct ownership by 19% to 43,170 units (SEC Form 4)

SEC Form 4 filed by CEO-elect Durso Jerome Benedict

Chief Financial Officer Weaver Gregory L converted options into 18,750 shares and covered exercise/tax liability with 5,672 shares, increasing direct ownership by 131% to 23,078 units (SEC Form 4)

SEC Form 4 filed by Chief Financial Officer Weaver Gregory L

SEC Form 4 filed by Chief Medical Officer Arbet-Engels Christophe

SEC Form 4 filed by Director Sohn Catherine A.

SEC Form 4 filed by Director Durso Jerome Benedict

SEC Form 4 filed by Director Lawver Teri L

SEC Form 4 filed by Director Jorkasky Diane

Director Gill John gifted 2,714 shares, closing all direct ownership in the company (SEC Form 4)

SEC Form 4 filed by Director Schafer Klaus

SEC Form 4 filed by Director Sayare Mitchel

SEC Form 4 filed by Director Hodges Philip

SEC Form 4 filed by Director Pisano Wayne

SEC Form 4 filed by Chief Commercial Officer Richardson Linda M

Chief Business Officer Jordt Raymond M was granted 1,368 shares, increasing direct ownership by 4% to 36,270 units (SEC Form 4)

Chief Medical Officer Harris Matthew Scott was granted 2,018 shares, increasing direct ownership by 14% to 16,087 units (SEC Form 4)

Chief Scientific Officer Roberts M Scot was granted 846 shares, increasing direct ownership by 1% to 74,066 units (SEC Form 4)

Chief Medical Officer Harris Matthew Scott gifted 67,787 shares (SEC Form 4)

SEC Form 4 filed by Director Lawver Teri L

SEC Form 4 filed by Director Durso Jerome Benedict

SEC Form 4 filed by Director Sohn Catherine A.

President and CEO Garg Vipin K converted options into 62,270 shares, covered exercise/tax liability with 27,214 shares and was granted 4,105 shares, increasing direct ownership by 12% to 355,082 units (SEC Form 4)

Chief Medical Officer Harris Matthew Scott converted options into 23,216 shares, covered exercise/tax liability with 7,990 shares and was granted 1,905 shares, increasing direct ownership by 26% to 81,856 units (SEC Form 4)

Chief Business Officer Jordt Raymond M was granted 2,614 shares, increasing direct ownership by 8% to 34,902 units (SEC Form 4)

Chief Scientific Officer Roberts M Scot converted options into 23,216 shares, covered exercise/tax liability with 6,826 shares and was granted 3,184 shares, increasing direct ownership by 36% to 73,220 units (SEC Form 4)

Chief Scientific Officer Roberts M Scot converted options into 14,600 shares and covered exercise/tax liability with 4,264 shares, increasing direct ownership by 24% to 53,646 units (SEC Form 4)

Chief Business Officer Jordt Raymond M converted options into 14,600 shares and covered exercise/tax liability with 3,862 shares, increasing direct ownership by 50% to 32,288 units (SEC Form 4)

Chief Medical Officer Harris Matthew Scott converted options into 14,600 shares and covered exercise/tax liability with 4,994 shares, increasing direct ownership by 17% to 64,725 units (SEC Form 4)

President and CEO Garg Vipin K converted options into 42,050 shares and covered exercise/tax liability with 18,157 shares, increasing direct ownership by 8% to 315,921 units (SEC Form 4)

Chief Business Officer Jordt Raymond M converted options into 9,375 shares and covered exercise/tax liability with 2,485 shares, increasing direct ownership by 47% to 21,550 units (SEC Form 4)

SEC Form 4 filed by Chief Financial Officer Weaver Gregory L

SEC Form 4 filed by Director Pisano Wayne

SEC Form 4 filed by Director Hodges Philip

SEC Form 4 filed by Director Sayare Mitchel

SEC Form 4 filed by Director Schafer Klaus

SEC Form 4 filed by Director Gill John

SEC Form 4 filed by Director Jorkasky Diane